| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 126.888 | 82.171 | 101.954 | 58.720 | 36.003 | 169.736 | 599.610 | 772.502 | 852.145 | 96.281 |
| Total Income - EUR | 128.993 | 84.275 | 116.259 | 61.177 | 54.953 | 207.288 | 610.548 | 785.644 | 880.520 | 125.483 |
| Total Expenses - EUR | 127.720 | 82.899 | 94.230 | 73.091 | 51.529 | 204.235 | 525.087 | 763.267 | 967.395 | 197.975 |
| Gross Profit/Loss - EUR | 1.273 | 1.376 | 22.029 | -11.914 | 3.424 | 3.053 | 85.461 | 22.377 | -86.875 | -72.492 |
| Net Profit/Loss - EUR | 590 | 1.040 | 20.919 | -12.508 | 3.055 | 1.090 | 79.984 | 15.229 | -90.584 | -72.492 |
| Employees | 0 | 6 | 1 | 2 | 2 | 3 | 3 | 4 | 4 | 1 |
Check the financial reports for the company - Drogobata Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 81.453 | 80.622 | 89.109 | 85.238 | 85.316 | 70.656 | 67.985 | 89.877 | 164.805 | 118.743 |
| Current Assets | 80.976 | 60.609 | 50.969 | 50.207 | 49.725 | 59.011 | 148.678 | 125.889 | 206.074 | 136.317 |
| Inventories | 2.209 | 0 | -71 | 0 | 0 | 0 | 46.150 | 85.689 | 197.456 | 95.654 |
| Receivables | 73.712 | 59.361 | 50.893 | 49.494 | 49.639 | 32.733 | 83.694 | 70.742 | 56.458 | 37.370 |
| Cash | 5.055 | 1.248 | 146 | 713 | 85 | 26.278 | 18.834 | -30.542 | -47.839 | 3.293 |
| Shareholders Funds | 104.867 | 104.837 | 123.982 | 109.199 | 110.139 | 109.141 | 186.705 | 139.942 | 34.034 | -38.649 |
| Social Capital | 48 | 47 | 47 | 46 | 45 | 44 | 43 | 43 | 43 | 43 |
| Debts | 68.858 | 47.575 | 27.087 | 26.246 | 24.902 | 20.527 | 29.958 | 75.824 | 336.846 | 293.709 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "129 - 129" | |||||||||
| CAEN Financial Year |
220
|
|||||||||
Comments - Drogobata Srl